The biggest deal of 2020?
Published 01-DEC-2020 09:57 A.M.
|
3 minute read
Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.
In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.
The below articles were written under our previous business model. We have kept these articles online here for your reference.
Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.
Click Here to View Latest Articles
While Salesforce’s talks to acquire Slack dominated headlines late last week, there could; be an even bigger deal int hew works.
According to eToro analyst Adam Vettese, The WSJ, financial information firm S&P Global is in advanced talks to buy fellow data giant IHS Markit for $44BN. If that price stands, the deal would be the largest in the US this year.
According to Vettese there is plenty going on to round out the year.
“Short-term rentals platform Airbnb and food delivery firm DoorDash are set to reveal higher-than-expected valuation ranges for their initial public offerings in roadshows this week. Bloomberg reported that Airbnb will target a valuation range of $30BN to $33BN, while DoorDash shoots for $25BN to $28BN. A host of companies are currently pushing to complete IPOs before the end of the year, including loan company Affirm, discount retailer Wish and gaming company Roblox."
As for the markets generally, Joshua Mahony, Senior Market Analyst at IG says “Gains throughout much of Europe come as the vaccine-led recovery boosts value names. UK efforts to reopen for the festive period should help alleviate businesses losses, but they also raise questions over a third wave. Meanwhile, OPEC reconvenes as crude heads lower.
“European markets are grinding higher in early trade, marking a distinct change from the largely pessimistic tone struck in Asia overnight.
“With vaccine announcements helping to lift sentiment over the past three Mondays, we look set for the best month on record for the FTSE 100.
“That vaccine hope should drive European outperformance in the months ahead, with November seeing a shift from growth to value that should continue to help drive lagging indices such as the FTSE 100, CAC, Ibex, and FTSE MIB.
“While the reversal of that growth/value dynamic looks likely to continue as the vaccines take hold, the short-term economic pain seen off the back of widespread economic restrictions should ensure a more balanced market view after recent gains.
“Crude prices have been hit in early trade, as weekend OPEC negotiations hint at a somewhat less one-sided debate than many had hoped for.
“Recent vaccine announcements have helped lift hopes of a sharp rebound in demand for crude, yet the question now is how much energy should be priced based on the future prospective demand or current reality.
“From an OPEC perspective, the question is whether foster this recovery or send energy prices lower once again.
“The two-million barrels per day increase that would come in the absence of a deal would deal a serious blow to market sentiment as much as supply/demand levels themselves, indicating that the group are unwilling to support energy prices until demand returns.”
Tickers
Dow: -0.91%
S&P 500: -0.46%
NASDAQ: -0.06%
FTSE 100: - 1.59%
DAX: - 0.33%
CAC 40: - 1.42%
Asia Dow: - 2.17%
Nikkei 225: - 0.79%
Hang Seng: - 2.06%
ASX 200: - 1.26%
AUD: 0.73
General Information Only
S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.
Conflicts of Interest Notice
S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.
Publication Notice and Disclaimer
The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.
Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.
This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.